CHU de Nice - Hôpital de l'Archet, Nice, Alpes-maritimes, France - 19 Oct `22Blood-cell mitochondria study in vitiligo

Blood-cell mitochondria study in vitiligo

Official title: Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients as Compared to Controls

Status: Closed to new participants

Description:

Centre Hospitalier Universitaire de Nice enrolled about 59 participants. This study measures how mitochondria, the energy-producing parts of cells, behave in people with vitiligo. The findings may reveal a biological marker or future treatment target, but participants do not receive an experimental vitiligo drug. Participation risks are mainly those of a blood draw, such as brief pain, bruising, dizziness, or rarely infection. People ages 18 to 80 may qualify. The study is underway but is no longer accepting new participants.

Start date: October 19, 2022

Completion date: June 30, 2025

Organizer: Centre Hospitalier Universitaire de Nice

Contact: passeron thierry, PhD

Link: https://clinicaltrials.gov/study/NCT05525741

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Blood-cell mitochondria study in vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions